Vedanta Associates-R, LP, 10% Owner, Director at REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), bought 1,330,000 shares at $3.75 ($5.0M) on 2021-06-01, disclosed to the SEC on 2021-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 399,000 | $1.5M | 30.0% |
| 2 | $3.75 | 931,000 | $3.5M | 70.0% |
| Total | $3.75 avg | 1,330,000 | $5.0M | 100% |